$SPOK

COURNOYER CHRISTINE sold $94K of SPOK

COURNOYER CHRISTINE sold 8,320 shares of Spok Holdings, Inc (SPOK) at $11.28 on 2026-08-10.

Original reporting
SEC EDGAR · COURNOYER CHRISTINE
Published Aug 11, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 11, 2026, 8:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SPOK
Neutral
medium confidence
Mentioned
$SPOK
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SPOKNeutralLow
01

Why it matters

A director open-market sale is disclosed, including share count, price, and post-transaction holdings, but no company-specific catalyst is provided.

02

Market read

Traders may note the insider sale, but there is no accompanying fundamental update in the text.

03

What to watch

Insider sales can be driven by diversification, taxes, or pre-existing personal liquidity needs; without additional filings or company news, signal quality is limited.

Relevance 3/10Novelty 3/10Timing: filed 2026-08-11, sale dated 2026-08-10

Background

The article is an SEC Form 4 insider transaction disclosure for Spok Holdings, Inc.

Company-level read

Ticker impact

$SPOKNeutralMedium confidence
Context

SEC Form 4 shows director COURNOYER CHRISTINE sold 8,320 SPOK shares on 2026-08-10 at $11.2824.

Expected impact

Likely minimal near-term impact; any effect would be sentiment-only and typically fades.

Evidence & confidence

The filing discloses transaction size and price but provides no new operational, financial, or regulatory information about Spok Holdings.

Market effects

No clear sector read-through from a single director sale.

None indicated.

None indicated.

Counterpoint

Insider sales without a stated 10b5-1 plan can be interpreted as caution, but the article provides no context for motive or future guidance.

Key entities

  • Spok Holdings, Inc

    Subject of the Form 4 insider transaction disclosure.

  • COURNOYER CHRISTINE

    Director who sold 8,320 shares in an open-market sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SPOKMed

Spok Reports Second Quarter 2026 Results

Spok Holdings, Inc (SPOK) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NEWS RELEASE CONTACT: Al Galgano 952-224-6096 al.galgano@spok.com Spok Reports Second Quarter 2026 Results Company Generates $4.1 Million of Net Income and $9.1 Million of Adjusted EBITDA Software Operations Bookings Up Nearly 92% From the Prior Quarter Executes Agre

$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).